title: Hair: what is new in diagnosis and management? Female pattern hair loss update: diagnosis and treatment.
abstract: Female pattern hair loss (FPHL) is the most common cause of alopecia in women. FPHL is characterized histologically with increased numbers of miniaturized, velluslike hair follicles. The goal of treatment of FPHL is to arrest hair loss progression and stimulate hair regrowth. The treatments for FPHL can be divided into androgen-dependent and androgen-independent. There is an important adjuvant role for nutritional supplements, light therapy, and hair transplants. All treatments work best when initiated early. Combinations of treatments tend to be more efficacious.
authors.affiliation: Department of Dermatology, Dermatology and Plastic Surgery Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
authors.forename: Natasha
authors.initials: N
authors.lastname: Atanaskova Mesinkovska
authors.forename: Wilma F
authors.initials: WF
authors.lastname: Bergfeld
mesh_terms: D058888:14-alpha Demethylase Inhibitors / Q000627:therapeutic use*; D000505:Alopecia / Q000175:diagnosis* / Q000628:therapy; D000726:Androgen Antagonists / Q000627:therapeutic use*; D005260:Female; D006197:Hair / Q000254:growth & development / Q000637:transplantation*; D006801:Humans; D007654:Ketoconazole / Q000627:therapeutic use; D008914:Minoxidil / Q000627:therapeutic use; D010789:Phototherapy / Q000379:methods; D019736:Prostheses and Implants; D012720:Severity of Illness Index; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D058888:14-alpha Demethylase Inhibitors; D000726:Androgen Antagonists; D014665:Vasodilator Agents; D008914:Minoxidil; D007654:Ketoconazole